Skip to main content
Back

Posttranscriptional Regulation in Eukaryotes: Mechanisms and Biological Implications

Study Guide - Smart Notes

Tailored notes based on your materials, expanded with key definitions, examples, and context.

Posttranscriptional Regulation in Eukaryotes

Introduction to Posttranscriptional Regulation

Posttranscriptional regulation encompasses all mechanisms that control gene expression after transcription has occurred but before translation into protein. These processes are essential for generating protein diversity, fine-tuning gene expression, and responding to cellular signals. Major mechanisms include alternative splicing, mRNA stability and degradation, noncoding RNAs, mRNA localization, and posttranslational modifications.

  • Alternative splicing – Generates multiple mRNA isoforms from a single gene.

  • mRNA stability and degradation – Determines the lifespan of mRNA molecules.

  • Noncoding RNAs – Regulate gene expression through RNA interference and other mechanisms.

  • mRNA localization and translation initiation – Control where and when proteins are synthesized.

  • Posttranslational modifications – Regulate protein activity after translation.

Overview of gene expression from DNA to protein, highlighting posttranscriptional steps

Regulation of Alternative Splicing

Alternative Splicing Creates Diversity in Gene Isoforms

Alternative splicing is a process by which different combinations of exons are joined together to produce multiple mRNA variants (isoforms) from a single pre-mRNA transcript. This mechanism greatly expands the proteome, allowing a limited number of genes to encode a vast array of proteins with distinct functions.

  • Isoforms – Protein variants produced from the same gene via alternative splicing.

  • At least two-thirds of human protein-coding genes undergo alternative splicing, resulting in over 290,000 protein isoforms from about 22,000 genes.

Diagram showing how alternative splicing generates different mRNAs and proteins from the same gene

Types of Alternative Splicing

  • Constitutive splicing – All exons are included in the mature mRNA ("normal" splicing).

  • Exon skipping (cassette exons) – Specific exons may be included or excluded from the final mRNA. This is the most common form, accounting for 30–40% of events.

Constitutive splicing and exon skipping illustrated

  • Alternative splice sites – Use of different 5' or 3' splice sites within an exon, resulting in inclusion of different exon segments.

Alternative 5' and 3' splice site selection

  • Intron retention – Introns are retained in the mature mRNA, which can lead to novel protein isoforms or mRNA degradation.

  • Mutually exclusive exons – Only one of two (or more) exons is included in the mature mRNA, allowing for domain swapping in proteins.

Intron retention and mutually exclusive exons

Regulation of Alternative Splicing

Alternative splicing is regulated by cis-acting sequence elements and trans-acting protein factors:

  • Splicing enhancers (ESE/ISE) – Sequences that promote splicing, bound by SR proteins.

  • Splicing silencers (ESS/ISS) – Sequences that inhibit splicing, bound by hnRNPs.

  • Spliceosome components (U1, U2 snRNPs) – Catalyze the splicing reaction.

Diagram of splicing enhancers, silencers, and associated proteins

Example: A mutation in an intronic splice enhancer (ISE) can lead to exon skipping or intron retention, potentially resulting in nonfunctional proteins due to frameshifts or premature stop codons.

Biological Significance and Examples of Alternative Splicing

  • Calcitonin gene – Alternative splicing and polyadenylation produce different hormones in thyroid versus neuronal cells.

Calcitonin gene alternative splicing in different tissues

  • Dscam gene in Drosophila – Can generate 38,016 different protein isoforms, crucial for neuronal identity during development.

Dscam gene alternative splicing diversity

Clinical Relevance: Spinal Muscular Atrophy (SMA)

Spinal Muscular Atrophy is a neurodegenerative disease caused by defective splicing of the SMN2 gene, leading to loss of motor neurons and muscle atrophy. The disease is autosomal recessive and is a leading genetic cause of infant mortality.

  • SMN2 gene – A single nucleotide change disrupts a splice enhancer, causing exon 7 exclusion in most transcripts and resulting in nonfunctional protein.

  • SMN1 gene – Normally produces functional SMN protein; loss of SMN1 function leads to SMA.

Motor neuron structure Infant with SMA Child with SMA in wheelchair SMN1 and SMN2 gene splicing and protein production

Therapeutic Approaches: Spinraza (Nusinersen)

Spinraza is an antisense oligonucleotide therapy that modulates SMN2 splicing by blocking an intronic splicing silencer (ISS-N1), increasing exon 7 inclusion and production of functional SMN protein.

  • Administered via intrathecal injection into the spinal cord.

  • Significantly improves outcomes for SMA patients but is costly.

Spinraza injection site in spinal cord Spinraza mechanism of action on SMN2 splicing

Gene Expression Regulation by mRNA Stability and Degradation

mRNA Decay Pathways

The steady-state level of mRNA in a cell is determined by the balance between transcription and degradation. mRNA decay is a key regulatory step in gene expression.

  • Deadenylation-dependent decay – Shortening of the poly-A tail by exoribonucleases destabilizes mRNA.

  • Decapping – Removal of the 5' cap structure makes mRNA susceptible to degradation.

  • Endonucleolytic cleavage – Internal cleavage of mRNA leads to rapid degradation.

Regulation of mRNA Stability

  • Adenosine–uridine rich elements (AREs) – Cis-acting sequences in the 3' UTR that regulate mRNA stability.

  • Trans-acting proteins – Bind to AREs to stabilize or destabilize mRNA (e.g., HuR stabilizes mRNA).

mRNA stability and ARE-mediated regulation

Noncoding RNAs in Posttranscriptional Regulation

Types and Functions of Noncoding RNAs (ncRNAs)

Noncoding RNAs do not encode proteins but play crucial roles in gene regulation, including RNA interference (RNAi), splicing, and chromatin modification.

  • siRNA (small interfering RNA) – Derived from double-stranded RNA, induces mRNA degradation.

  • miRNA (microRNA) – Endogenously encoded, regulates gene expression by translational repression or mRNA cleavage.

Types of noncoding RNAs

Mechanism of RNA Interference (RNAi)

  • Double-stranded RNA is processed by Dicer into siRNAs or miRNAs.

  • siRNAs/miRNAs are loaded onto the RISC (RNA-induced silencing complex).

  • RISC uses the guide strand to target complementary mRNA for cleavage or translational inhibition.

siRNA pathway: Dicer processing, RISC loading, mRNA cleavage miRNA pathway: Dicer processing, RISC loading, translational inhibition or mRNA cleavage

mRNA Localization and Translational Control

Cytoplasmic Polyadenylation and Translational Activation

Some mRNAs are stored in a translationally dormant state and activated only in response to specific signals. The cytoplasmic polyadenylation element (CPE) in the 3' UTR is recognized by CPEB, which recruits proteins to repress or activate translation.

  • Phosphorylation of CPEB by kinases triggers poly-A tail elongation and translation initiation.

Cytoplasmic polyadenylation and translational activation

mRNA Localization and Localized Translation

mRNA localization ensures that proteins are synthesized at the correct cellular location. The 3' UTR zip code sequence binds ZBP1, which transports mRNA to specific sites and blocks translation until localization is achieved.

mRNA localization and localized translation in the cell

Posttranslational Modifications Regulate Protein Activity

Phosphorylation

Phosphorylation is the most common posttranslational modification, regulating protein function by adding phosphate groups to serine, threonine, or tyrosine residues. Kinases catalyze phosphorylation, while phosphatases remove phosphates. This modification can activate or inactivate proteins, alter their interactions, or change their cellular localization.

  • Kinases – Enzymes that add phosphate groups using ATP.

  • Phosphatases – Enzymes that remove phosphate groups.

Protein phosphorylation and activation Phosphorylation-induced conformational change Kinase activation by phosphorylation Kinase inactivation by dephosphorylation

Ubiquitin-Mediated Protein Degradation

Ubiquitination targets proteins for degradation by the proteasome. Ubiquitin ligases attach ubiquitin molecules to lysine residues on substrate proteins, marking them for recognition and breakdown by the proteasome into small peptides.

Ubiquitin-mediated protein degradation pathway

Integrated Regulation Example: TNFα mRNA Stability

The stability of TNFα mRNA is regulated by the binding of TTP to AREs in the 3' UTR. When TTP is unphosphorylated, it recruits the Cnot deadenylase complex, promoting mRNA decay. Phosphorylation of TTP prevents this interaction, stabilizing the mRNA and increasing protein production. This is a classic example of posttranscriptional regulation modulated by posttranslational modification.

Regulation of TNFα mRNA stability by TTP phosphorylation

Summary Table: Major Mechanisms of Posttranscriptional Regulation

Mechanism

Description

Key Players

Biological Outcome

Alternative Splicing

Generation of multiple mRNA isoforms from one gene

SR proteins, hnRNPs, spliceosome

Protein diversity

mRNA Stability/Degradation

Regulation of mRNA half-life

AREs, HuR, TTP, deadenylases

Control of protein levels

Noncoding RNAs

Gene silencing via RNAi

siRNA, miRNA, RISC, Dicer

Translational repression or mRNA cleavage

mRNA Localization

Transport and local translation of mRNA

Zip code, ZBP1

Spatial control of protein synthesis

Posttranslational Modification

Regulation of protein activity after translation

Kinases, phosphatases, ubiquitin ligases

Protein activation/inactivation, degradation

Pearson Logo

Study Prep